Digital Therapeutics: Everything You Need to Know
In this episode, Tom Caravela welcomes Madleine Makori to discuss her career journey and passion for the MSL role, with a particular focus on digital therapeutics. Madleine shares insights into the differentiation and challenges of digital therapeutics and how COVID-19 has accelerated technology adaptation for patient populations. The conversation delves into the growing collaborations in digital therapeutics and the increasing provider interest in this field. Madleine highlights expanding opportunities for MSLs in tech and the importance of education in this evolving area. The episode concludes with an invitation for audience engagement and a call to subscribe.
Madleine Makori, Sr Medical Science Liaison at Big Health discusses everything you need to know about Digital Therapeutics
Maddy explains…
👉 What is Digital Therapeutics and how it differs from wellness and lifestyle apps
👉 How Digital Therapeutics is making an impact on the pharmaceutical industry
👉 The impact of Covid-19 and the development of the space
👉 What opportunities may emerge and what it means for Medical Affairs
👉 What the future looks like for the Digital Therapeutics space and what people need to know
The podcast is available through the links below:
️ ️ 〰️ Spotify: https://lnkd.in/dRrSEyn
️ ️ 〰️ Apple: https://lnkd.in/egSthAz
️ ️ 〰️ Stitcher: https://lnkd.in/eqB-2wb
📣 Now on YouTube 📣
Please subscribe: https://www.youtube.com/channel/UCS7XTUuk1XF5Tm5InADY6cA
📣 Now on Instagram 📣
Please subscribe:
https://www.instagram.com/msl_talk_podcast/
MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.
#msl #medicalaffairs #medicalscienceliaison #aspiringmsl #MSLTalk
Chapters
| 0:00 | |
| 1:02 | |
| 4:28 | |
| 6:42 | |
| 16:43 | |
| 23:09 | |
| 25:20 | |
| 27:46 | |
| 30:18 | |
| 31:44 |
Transcript
Loading transcript...